Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Longitudinal change in magnetic susceptibility of new enhanced multiple sclerosis (MS) lesions measured on serial quantitative susceptibility mapping (QSM).
Inhibin-a immunoreactivity in nervous system lesions.
Neuropsychological, balance and mobility risk factors for falls in people with multiple sclerosis: a prospective cohort study.
Molecular dynamics and intracellular signaling of the TNF-R1 with the R92Q mutation.
Variations in and predictors of the occurrence of depressive symptoms and mood symptoms in multiple sclerosis: a longitudinal two-year study.
Antimalarial Drug Artemether Inhibits Neuroinflammation in BV2 Microglia Through Nrf2-Dependent Mechanisms.
Absence of MxA induction is related to a poor clinical response to interferon beta treatment in multiple sclerosis patients.
Erratum: Genomic analysis of ERVWE2 locus in patients with Multiple sclerosis: absence of genetic association but potential role of Human Endogenous retrovirus type W elements in molecular mimicry with myelin antigen.
Occupational Therapy Interventions for Adults With Multiple Sclerosis.
Acute disseminated encephalomyelitis: case report and brief review.
Peloruside A: a lead non-taxoid-site microtubule-stabilizing agent with potential activity against cancer, neurodegeneration, and autoimmune disease.
In multiple sclerosis, use of fingolimod reduced immune responses to influenza and tetanus booster vaccines.
[Balance disorder and subacute hydrocephalus due to haemorrhage in a cerebral cavernous malformation].
Spatial and temporal characteristics of gait as outcome measures in multiple sclerosis (EDSS 0 to 6.5).
[Epidemiology of multiple sclerosis].
Brain cytokines and disease.
Role of Sortilin in Models of Autoimmune Neuroinflammation.
Cytoskeletal Linker Protein Dystonin Is Not Critical to Terminal Oligodendrocyte Differentiation or CNS Myelination.
Pediatric multiple sclerosis.
Evoked potentials are useful for diagnosis of neuromyelitis optica spectrum disorder.
Favorable outcome of granulocyte colony-stimulating factor use in neuromyelitis optica patients presenting with agranulocytosis in the setting of rituximab.
Anti-neuropathic effects of Rosmarinus officinalis L. terpenoid fraction: relevance of nicotinic receptors.
Targeting specific cells in the brain with nanomedicines for CNS therapies.
Neurourologic dysfunction: evaluation, surveillance and therapy.
Fatigue and heat sensitivity in patients with multiple sclerosis.
Pages
« first
‹ previous
…
675
676
677
678
679
680
681
682
683
…
next ›
last »